Abstract
Objective
To investigate the expression of RECK mRNA and protein in esophageal squamous cell carcinoma (ESCC) and to examine its relationship with the clinicopathologic features.
Methods
The expression of RECK mRNA and protein in 62 cases of ESCC, 31 of paraneoplastic atypical hyperplasia (PAH) and 62 normal esophageal mucous membrane specimens was examined, using RT-PCR and immunohistochemistry.
Results
During canceration of the ESCC, the mRNA of RECK increased sequentially from ESCC tissue to PAH and normal mucous membranes. Values were 1.052±0.078, 1.274±0.235 and 1.306±0.121, respectively, with a significant difference among different groups (F=49.936, P<0.05). There was a statistically significant difference in the relative amount of the RECK mRNA among the ESCC tissues at various levels of differentiation, depth of infiltration, and different types of lymph node metastasis (F=5.081, F=26.084, U=24.011, P<0.05). In the ESCC tissue and PAH, the positive rates of RECK protein expressions were lower compared to the normal mucosa tissue, i.e. 59.7% (37/62), 71.0% (22/31) and 85.5% (53/62), respectively. There was a significant difference among the inter-group comparisons (χ2=10.331, P<0.01). In ESCC, there was a close correlation between the RECK protein expression and the degree of cancer differentiation, and the depth of invasion and the types of ESCC lymph node metastasis (P<0.05).
Conclusion
The decrease in expression of both RECK mRNA and protein in ESCC suggest that these low expressions may relate to ESCC development. Examination of RECK mRNA and protein expression may develop into one of the molecular indices for early ESCC diagnosis and prognosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 1998; 95: 13221–13226.
Span PN, Sweep CG, Manders T, et al. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer 2003; 97: 2710–2715.
Chang HC, Cho CY, Hung WC. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci 2007; 98: 169–173.
da Silva Cardeal LB, Brohem CA, et al. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol 2006; 84: 713–719.
Hao BL, Li SS, Zhang HY et al. Expression and significance of the EPHA2 gene in esophageal carcinoma. Chin J Clin Oncol 2006; 33: 555–558 (in Chinese).
Li YL. Pathology. 6th Ed. Bei**g: People’s Medical Publishing House. 2004; 113–117 (in Chinese).
Sasahara RM, Takahashi C, Noda M. Involvement of the Sp1site in ras-mediated down regulation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun 1999; 264: 668–675.
Takenaka K, Ishikawa S, Kawano Y, et a1. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. Eur J Cancer 2004; 40: 1617–1623.
Masui T, Doi R, Koshiba T, et al. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res 2003; 9: 1779–1784.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by a grant from the Key-Faculty Construction Fund for Project 211 of the 10th Five-Year Plan of the Ministry of Education [Jiaozhongban (2002) No.2].
About this article
Cite this article
Li, S., Liu, Z., Zhao, Q. et al. The expression of RECK mRNA and protein in esophageal squamous cell carcinoma and its clinical significance. Chin. J. Clin. Oncol. 5, 26–29 (2008). https://doi.org/10.1007/s11805-008-0026-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11805-008-0026-2